ani opinion burzynski 's antineoplaston inform current status research would appreci . 
burzynski 's work promis . 
none a-1 a-5 antineoplaston shown antineoplast effect experiment cancer . 
the nci conduct test a-2 a-5 leukemia mice result dose high enough produc toxic effect mice effect inhibit growth tumor kill . 
these 1983 1985 burzynski claim a-10 activ factor common a-1 a-5 someth shown a-10 extract a-2 . 
he also n't shown a-1 a-5 actual distinct substanc . 
the nci conduct seri test use a-10 standard panel tumor includ differ cell line tumor follow class leukemia non-small-cel small-cel lung cancer colon cancer cancer central nervous system melanoma ovarian cancer renal cancer . 
a-10 exhibit neither growth inhibit cytotox dose level test . 
it necessari process a-10 sinc solubl burzynski 's theori requir solubl agent basic hydrol pag call as 2.5 . 
pag inform carri peptid someth byrzynski claim necessari antineoplast activ . 
as 2.1 also deriv a-10 41 mixtur pa pag . 
pa also peptid purchas chemic suppli hous 0.09 gram . 
a-10 chemic extrem similar glutithamid thalidomid habit form caus peripher neuropathi . 
the nasti effect thalidomid wide known . 
in spite similar a-10 appear test 's potenti induc teratogen peripher neuropathi . 
mani burzynski 's statement origin theori earli research past present support other work shown untru . 
sdb 
